With the new regulation from the Ministry of Health, pharmacists will benefit equally from the exchange rate increases in drug prices. The aim of the regulation is to prevent pharmacists from experiencing income loss. In the statement made by the Ministry of Health regarding the regulation published in the Official Gazette yesterday, it was stated that drug prices are updated annually according to the periodical euro exchange rate changes and in accordance with the “Regulation on Pricing of Human Medicinal Products.” It was noted in the statement that this update is based on a certain percentage of the average euro value of the previous year, and the current value is determined within the framework of budget discipline as in other countries. The statement also mentioned that the regulation covers not only human-made products but also imported drugs. It was mentioned in the statement that since updates are not made annually in the current regulation, pharmacy profit margins remain fixed. Therefore, many drugs are sold with low profitability rates by exceeding the upper limit of profit margin. It was stated in the statement that for pharmacies, profitability margins are applied as 28% for first level drugs (up to 328 liras), 18% for second level drugs (328-657 liras), and 13% for third level drugs (above 657 liras). In the regulation published in the Official Gazette yesterday, it was stated in the statement that this will provide a significant advantage for pharmacists and it was mentioned, “Pharmacists’ profitability levels will be redefined with each exchange rate update period from now on. In other words, the basic drug price levels that form the basis of pharmacists’ profits will increase proportionally with the updates in drug prices. Pharmacists will benefit equally from the drug price increases, preventing income losses.”